spacer
spacer

PDBsum entry 6be4

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Immune system PDB id
6be4

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
217 a.a.
213 a.a.
Ligands
NAG-NAG-NAG-NAG-
NAG
Waters ×485
PDB id:
6be4
Name: Immune system
Title: Crystal structure of a polysaccharide-binding human fab (f598) in complex with nona-n-acetyl-d-glucosamine (9nac)
Structure: Fab (f598) heavy chain. Chain: h. Engineered: yes. Fab(f598) light chain. Chain: l. Engineered: yes
Source: Homo sapiens. Organism_taxid: 9606. Expressed in: cricetulus griseus. Expression_system_taxid: 10029. Expression_system_taxid: 10029
Resolution:
1.90Å     R-factor:   0.166     R-free:   0.210
Authors: C.Soliman,P.A.Ramsland
Key ref: C.Soliman et al. (2018). Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-N-acetylglucosamine. J Biol Chem, 293, 5079-5089. PubMed id: 29449370
Date:
24-Oct-17     Release date:   21-Feb-18    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
No UniProt id for this chain
Struc: 217 a.a.
Protein chain
No UniProt id for this chain
Struc: 213 a.a.
Key:    Secondary structure

 

 
J Biol Chem 293:5079-5089 (2018)
PubMed id: 29449370  
 
 
Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-N-acetylglucosamine.
C.Soliman, A.K.Walduck, E.Yuriev, J.S.Richards, C.Cywes-Bentley, G.B.Pier, P.A.Ramsland.
 
  ABSTRACT  
 
In response to the widespread emergence of antibiotic-resistant microbes, new therapeutic agents are required for many human pathogens. A non-mammalian polysaccharide, poly-N-acetyl-d-glucosamine (PNAG), is produced by bacteria, fungi, and protozoan parasites. Antibodies that bind to PNAG and its deacetylated form (dPNAG) exhibit promising in vitro and in vivo activities against many microbes. A human IgG1 mAb (F598) that binds both PNAG and dPNAG has opsonic and protective activities against multiple microbial pathogens and is undergoing preclinical and clinical assessments as a broad-spectrum antimicrobial therapy. Here, to understand how F598 targets PNAG, we determined crystal structures of the unliganded F598 antigen-binding fragment (Fab) and its complexes with N-acetyl-d-glucosamine (GlcNAc) and a PNAG oligosaccharide. We found that F598 recognizes PNAG through a large groove-shaped binding site that traverses the entire light- and heavy-chain interface and accommodates at least five GlcNAc residues. The Fab-GlcNAc complex revealed a deep binding pocket in which the monosaccharide and a core GlcNAc of the oligosaccharide were almost identically positioned, suggesting an anchored binding mechanism of PNAG by F598. The Fab used in our structural analyses retained binding to PNAG on the surface of an antibiotic-resistant, biofilm-forming strain of Staphylococcus aureus Additionally, a model of intact F598 binding to two pentasaccharide epitopes indicates that the Fab arms can span at least 40 GlcNAc residues on an extended PNAG chain. Our findings unravel the structural basis for F598 binding to PNAG on microbial surfaces and biofilms.
 

 

spacer

spacer